(2017) Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
(2015) What to make of cannabis and cognition in MS: In search of clarity amidst the haze.
(2015) Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
(2015) Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
(2015) Cannabis in multiple sclerosis treatment: possibilities and limits.
(2015) The therapeutic potential of cannabinoids for movement disorders.
(2015) Disease modifying nutricals” for multiple sclerosis.
(2014) Medical marijuana in neurology.
(2014) Cannabinoids: new promising agents in the treatment of neurological diseases.
(2013) Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.
(2012) What place for ▾ cannabis extract in MS?
(2012) Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids.
(2012) Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
(2012) Potential control of multiple sclerosis by cannabis and the endocannabinoid system.
(2012) Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
(2012) Cannabinoids for symptomatic therapy of multiple sclerosis.
(2011) Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
(2011) Role of cannabinoids in multiple sclerosis.
(2011) The multiplicity of action of cannabinoids: implications for treating neurodegeneration.
(2010) Cannabis-based medicines in multiple sclerosis–a review of clinical studies.
(2009) Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.
(2009) Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
(2009) Cannabidiol: a promising drug for neurodegenerative disorders?
(2009) A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.
(2008) The endocannabinoid system and multiple sclerosis.
(2008) Endocannabinoids in the retina: from marijuana to neuroprotection.
(2008) Non-conventional medicine and multiple sclerosis.
(2008) Multiple sclerosis, cannabinoids, and cognition.
(2007) Cannabinoid control of neuroinflammation related to multiple sclerosis.
(2007) Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
(2007) Multiple sclerosis as a painful disease.
(2007) Treatment for ataxia in multiple sclerosis.
(2006) Implication of cannabinoids in neurological diseases.
(2006) Complementary and alternative medicine: is there a role in multiple sclerosis?
(2006) A review of the evidence for efficacy of complementary and alternative medicines in MS.
(2004) Endocannabinoids and their involvement in the neurovascular system.
(2005) Cannabinoids in multiple sclerosis — therapeutically reasonable?
(2005) Alternative and complementary therapies in multiple sclerosis.
(2005) The safety of cannabinoids for the treatment of multiple sclerosis.
(2005) Emerging properties of cannabinoid medicines in management of multiple sclerosis.
(2004) Towards cannabis and cannabinoid treatment of multiple sclerosis.
(2004) Marijuana and multiple sclerosis.
(2004) Cannabinoids in multiple sclerosis: do they have a therapeutic role?
(2003) Cannabis and the brain.
(2003) The therapeutic potential of cannabis in multiple sclerosis.
(2003) Therapeutic potential of cannabinoids in CNS disease.
(2002) The therapeutic potential of the cannabinoids in neuroprotection.
(2002) Cannabinoids and multiple sclerosis.
(2002) Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
(2000) Treatments for fatigue in multiple sclerosis: a rapid and systematic review.